Navigation Links
Over 50% of “Best Heart Hospitals” in U.S. News & World Report Are Certified to Implant the SynCardia Total Artificial Heart
Date:8/8/2013

Tucson, Ariz. (PRWEB) August 08, 2013

SynCardia Systems, Inc., manufacturer of the world’s first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that over half of the top 50 centers honored in U.S. News & World Report’s “Best Hospitals” list for cardiology and heart surgery for 2013-2014, offer the SynCardia temporary Total Artificial Heart.

“The fact that these top U.S. transplant centers offer the SynCardia Total Artificial Heart demonstrates its growing acceptance as the new standard of care for end-stage biventricular heart failure,” said Michael Garippa, SynCardia CEO and President.

In June, U.S. News and World Report published its annual list of “Best Children’s Hospitals” for cardiology and heart surgery. Among the top 10 were seven pediatric centers that offer the SynCardia Total Artificial Heart: #2 Children's Hospital of Philadelphia (CHOP), #3 Texas Children's Hospital, #5 Cincinnati Children's Hospital Medical Center, #11 Children's Hospital of Wisconsin, #26 Mattel Children's Hospital UCLA, #32 Shands Hospital for Children at the University of Florida and #34 Phoenix Children's Hospital.

As of July 18, SynCardia Certified Centers worldwide have performed a record-breaking 100 implants of the SynCardia Total Artificial Heart in 2013. This milestone was achieved three months earlier than in 2012, when the 100th implant was performed on Oct. 16. Worldwide, there have been more than 1,200 implants of the Total Artificial Heart, accounting for more than 315 patient years of life.

There are currently 87 SynCardia Certified Centers worldwide, including 48 in the U.S. An additional 33 centers are currently completing SynCardia’s four-phase certification program.

###    

About the SynCardia temporary Total Artificial Heart

SynCardia Systems, Inc. (Tucson, AZ) is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. Originally used as a permanent replacement heart, the SynCardia Total Artificial Heart is currently approved as a bridge to transplant for people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure). There have been more than 1,200 implants of the Total Artificial Heart, accounting for more than 315 patient years of life on the device.

Similar to a heart transplant, the SynCardia Total Artificial Heart replaces both failing heart ventricles and the four heart valves. Unlike a donor heart, the Total Artificial Heart is immediately available at SynCardia Certified Centers. It is the only device that eliminates the symptoms and source of end-stage biventricular failure.

The Total Artificial Heart provides immediate, safe blood flow of up to 9.5 liters per minute through each ventricle. This high volume of blood flow helps speed the recovery of vital organs, helping make the patient a better transplant candidate.

Forbes Ranks SynCardia #69 Among "America's Most Promising Companies"

In its February 2013 issue, Forbes selected SynCardia as one of "America's Most Promising Companies" for the second consecutive year. On the list of 100 privately held, high-growth companies with bright futures, SynCardia was selected #69, moving up eight spots from its #77 ranking last year. See the full list of SynCardia Awards & Recognition here.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11008450.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Top 10 “Best Children’s Hospitals” Include 3 Pediatric Centers Offering SynCardia Total Artificial Heart
2. Indigo Biosystems Among “Best Places to Work” in Indiana
3. Probiotic Action The “Best Acne Treatment” Shares New Insight on the Future of Preventing the Spread of Acne Causing Germs
4. 7 SynCardia Certified Centers Honored Among “Best Children’s Hospitals” for Cardiology and Heart Surgery by U.S. News & World Report
5. Hong Kong Department of Health to Combat Sudden Cardiac Arrest With Powerheart AEDs
6. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
7. Post Heart Attack Recovery Not Aided By Stem Cell Injections, But Trial Demonstrates Promise
8. Gundersen Lutheran Offers Heart Surgery with Less Pain, Faster Recovery
9. LoneStar Heart Acquires Worldwide Exclusive Rights to New Class of Small Molecules That May Lead to New Treatments for Diabetes
10. Slovenias 1st Total Artificial Heart Patient Discharged from UMC Ljubljana Using the Freedom® Portable Driver
11. New Data Shows GeNO LLC Nitric Oxide Delivery System Provided Nitric Oxide With Low Levels of Nitrogen Dioxide for Heart Transplant Patient Evaluation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... , March 1, 2017  Trovagene, Inc. (NASDAQ: TROV), ... today that it will report financial results for the fourth ... 15, 2017. Trovagene,s senior management team will host ... p.m. Eastern Daylight Time (2:00 p.m. Pacific Daylight Time) to ... ...
(Date:3/1/2017)... SHANGHAI , March 1, 2017  Luxcel ... based Biotechnology Company and HD Biosciences Co., ... Research Organization (CRO), announced today that they have ... new assay technologies for preclinical drug safety services. ... Luxcel,s state-of-the-art assays and technologies for assessment of ...
(Date:3/1/2017)... Conn. (PRWEB) , ... March 01, 2017 , ... ... Group, Inc. will hold its annual technology show and open house, Southern Tech ... CNC machinery from Okuma, Tsugami, Hardinge Group and Chiron and perform live metal ...
(Date:2/28/2017)... ... February 28, 2017 , ... ... Inc. (Newark, DE) have formed a strategic partnership to develop and market ... renewable energy laboratories. These automated testing solutions will save analysis time and ...
Breaking Biology Technology:
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... by 2021 from $8.3 billion in 2016 at a ... to 2021. Report Includes - An overview of ... market trends, with data from 2015 and 2016, and ... - Segmentation of the market on the basis of ...
(Date:2/7/2017)... February 7, 2017 Ipsidy Inc. ... Corporation [OTC: IDGS], ("Ipsidy" or the "Company") a provider ... processing services, is pleased to announce the following changes ... Effective January 31, 2017, Philip D. Beck ... CEO and President.  An experienced payment industry professional and ...
(Date:2/3/2017)... , Feb. 3, 2017 A new independent ... Strategy Partners, LLP (IdSP) . Designed to fill a ... complex identity market, founding partners Mark Crego ... combined years just in identity expertise that span federal ... non-profit leadership. The Crego-Kephart combined expertise has a common ...
Breaking Biology News(10 mins):